TCT-164 Clinical Outcomes at 3 Years of the Absorb Bioresorbable Vascular Scaffold Versus Xience Drug-Eluting Metallic Stent in Patients With or Without Acute Coronary Syndrome: AIDA Trial Substudy

Coronary Syndrome ◽

Vascular Scaffold ◽

CLINICAL OUTCOMES AT 2 YEARS OF THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD VERSUS THE XIENCE DRUG-ELUTING METALLIC STENT IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME VERSUS STABLE CORONARY DISEASE: AIDA TRIAL SUB-STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(19)32009-1 ◽

2019 ◽

Vol 73 (9) ◽

pp. 1403

Author(s):

Ruben Tijssen ◽

Rene J. van der Schaaf ◽

Robin Kraak ◽

Laura S.M. Kerkmeijer ◽

Sjoerd H. Hofma ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Outcomes ◽

Coronary Disease ◽

Metallic Stent ◽

Coronary Syndrome ◽

Vascular Scaffold ◽

500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2019.01.141 ◽

2019 ◽

Vol 12 (4) ◽

pp. S39

Author(s):

Ruben Y.G. Tijssen ◽

Rene J. van der Schaaf ◽

Robin P. Kraak ◽

Maarten A. Vink ◽

Sjoerd H. Hofma ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Outcomes ◽

Coronary Disease ◽

Metallic Stent ◽

Coronary Syndrome ◽

Vascular Scaffold ◽

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.28193 ◽

2019 ◽

Vol 95 (1) ◽

pp. 89-96 ◽

Cited By ~ 2

Author(s):

Ruben Y.G. Tijssen ◽

Rene J. Schaaf ◽

Robin P. Kraak ◽

Maarten A. Vink ◽

Sjoerd H. Hofma ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Outcomes ◽

Coronary Disease ◽

Metallic Stent ◽

Coronary Syndrome ◽

Vascular Scaffold ◽

Clinical outcomes of bioresorbable vascular scaffold to treat all-comer patients. Are patients with acute coronary syndrome better candidates for bioresorbable vascular scaffold?

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2018.06.022 ◽

2019 ◽

Vol 20 (3) ◽

pp. 228-234

Author(s):

Fabien Picard ◽

Robert Avram ◽

Guillaume Marquis-Gravel ◽

Victor-Xavier Tadros ◽

Hung Q. Ly ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Outcomes ◽

Coronary Syndrome ◽

Vascular Scaffold ◽

Treat All

Long-term clinical outcomes of direct absorb bioresorbable vascular scaffold implantation in acute coronary syndrome

Minerva Cardioangiologica ◽

10.23736/s0026-4725.19.04854-0 ◽

2019 ◽

Vol 67 (5) ◽

Author(s):

Michal Wegiel ◽

Lukasz Rzeszutko ◽

Pawel Kleczynski ◽

Wojciech Zasada ◽

Rafal Depukat ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Outcomes ◽

Coronary Syndrome ◽

Vascular Scaffold

Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: a real world experience

Indian Heart Journal ◽

10.1016/j.ihj.2021.03.011 ◽

2021 ◽

Author(s):

Ahmed Ayuna ◽

Sherif Seif ◽

John MacDonald ◽

Ayyaz Sultan

Keyword(s):

Acute Coronary Syndrome ◽

Coronary Artery ◽

Clinical Outcomes ◽

Real World ◽

De Novo ◽

Coronary Artery Lesions ◽

Coronary Syndrome ◽

Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish National Registry

Advances in Interventional Cardiology ◽

10.5114/aic.2016.59360 ◽

2016 ◽

Vol 2 ◽

pp. 108-115 ◽

Cited By ~ 3

Author(s):

Łukasz Rzeszutko ◽

Zbigniew Siudak ◽

Tomasz Tokarek ◽

Krzysztof Plens ◽

Adrian Włodarczak ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Outcome ◽

Stable Angina ◽

National Registry ◽

Coronary Syndrome ◽

Vascular Scaffold

Clinical Outcomes after Treating Acute Coronary Syndrome Patients with a Drug-Eluting Stent: Results from REWARDS-EMI (Endeavor® for Myocardial Infarction Registry)

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2013.01.001 ◽

2013 ◽

Vol 14 (3) ◽

pp. 128-133 ◽

Cited By ~ 6

Author(s):

Danny Dvir ◽

Israel M. Barbash ◽

Rebecca Torguson ◽

Salem Badr ◽

Gabriel L. Sardi ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Clinical Outcomes ◽

Drug Eluting Stent ◽

Coronary Syndrome ◽

TCT-596 Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience – Results from CENTURY II trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.07.660 ◽

2014 ◽

Vol 64 (11) ◽

pp. B174

Author(s):

Kazushige Kadota ◽

William C. Wijns ◽

Shigeru Saito

Keyword(s):

Acute Coronary Syndrome ◽

High Risk ◽

Clinical Outcomes ◽

Drug Eluting Stent ◽

Coronary Syndrome ◽

Drug Eluting ◽

New Generation

Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?

EuroIntervention ◽

10.4244/eij-d-16-00472 ◽

2017 ◽

Vol 12 (16) ◽

pp. 2025-2027 ◽

Cited By ~ 3

Author(s):

Yohei Sotomi ◽

Yosuke Miyazaki ◽

Carlos Collet ◽

Taku Asano ◽

Pannipa Suwannasom ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Coronary Syndrome ◽

Vascular Scaffold